Pharmacy
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
FDA will begin notifying physicians that pregnant women should avoid taking Tylenol during pregnancy unless absolutely necessary.
Health plans will continue to cover recommended immunizations with no cost-sharing through the end of 2026, AHIP says.
The new model is intended to provide pharmacies with better financial means to stock more medicines, which is expected to alleviate drug shortages.
Reliance on the “big three” PBMs – CVS Caremark, Express Scripts and Optum Rx – has been slipping over the past year.
The group says an “unchecked” model would undermine the goal of allowing safety net providers to stretch federal resources.
Amneal Pharmaceuticals’ laboratory procedures resulted in visibly contaminated injectable medications, FDA says.
PBMs’ overseas group purchasing organizations may be used to avoid transparency and oversight, committee says.